You searched for metabolic diseases - Page 48 of 63

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

…the potentially life-threatening liver condition metabolic dysfunction-associated steatohepatitis (MASH), Rezdiffra received the green light from the U.S. Food and Drug Administration (FDA) to treat the disease back in March. MASH…

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

…drugs for metabolic diseases, before Sanofi then in-licensed one of the candidates in 2019. As it turned out, 2022 brought with it three more major AI deals for Sanofi. These…

November 2, 2023 - 8 minutesmins - By Willow Shah-Neville

astrazeneca phase III failure nsclc selumetinib

News and Trends 11 Aug 2016

This new Phase III Failure adds up to AstraZeneca’s Troubles

…was killing 6 programs. The cuts include small molecule programs for cardiometabolic diseases (such as NASH) and an antibody for asthma, but also several of MedImmune’s new identities for solid…

August 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

In Depth 30 Oct 2018

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

…with Danish diabetes giant, Novo Nordisk, to further develop their blood–brain barrier shuttle technology focussing on diabetes and metabolic diseases. Stowing drugs in exosome bubbles Over the past 10 years,…

October 30, 2018 - 7 minutesmins - By External Contributor

News and Trends 20 Mar 2017

French Biotech fails Second Phase II Trial for Cardiovascular Disease

…cardiovascular and metabolic diseases. The company now presented data on its lead candidate CER-001, which was investigated in a Phase II study for the treatment of patients with post-acute coronary…

March 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 24 Feb 2023

Beyond Biotech podcast 35: Rare Disease Day

…chronic medical conditions including autoimmune and metabolic diseases to improve the lives of patients. GRObio is applying its platform to advance partnered and collaborative programs, as well as its own…

February 24, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 11 Jan 2022

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

…of bispecific small molecule drugs for metabolic diseases, with Sanofi in-licensing one of the candidates in 2019. As part of the new deal, Exscientia will screen patient tissue data with…

January 11, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Jan 2023

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy

…discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno-oncology…

January 20, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 20 Jan 2023

DeuterOncology closes financing round to start lung cancer study

…overcomes this at source, having a metabolically-liable hydrogen replaced with a stronger bond strength deuterium atom. This significantly reduces the impact of this metabolic liability during treatment. The strength of…

January 20, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 Oct 2017

Meet some of the Hottest Startups of 2017!

…covering neuroscience, oncology, cardiovascular and metabolic diseases, immunology, infectious diseases, vaccines and pulmonary hypertension. Chosen startups will have the opportunity to present their innovative ideas to a panel of expert…

October 19, 2017 - 7 minutesmins - By External Contributor

News and Trends 9 May 2017

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

…believes using a bispecific drug approach that goes after more than one target can significantly increase the chances of success. Especially in metabolic diseases with high complexity such as diabetes….

May 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Sep 2021

The Top European Biotech Funding Rounds in August

…metabolic diseases involving the liver. And NRG Therapeutics in the UK closed a small seed investment of around £490,000 (€570,000) in a bid to treat Parkinson’s disease. One interesting seed…

September 10, 2021 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

The 2024 drug approval list: Eight new treatments you should know about

How French pharma giant Sanofi is betting big on AI

This new Phase III Failure adds up to AstraZeneca’s Troubles

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

French Biotech fails Second Phase II Trial for Cardiovascular Disease

Beyond Biotech podcast 35: Rare Disease Day

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy

DeuterOncology closes financing round to start lung cancer study

Meet some of the Hottest Startups of 2017!

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

The Top European Biotech Funding Rounds in August

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!